Cargando…
(18)F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma
OBJECTIVE: MET is a member of the receptor tyrosine kinases. Several MET-targeting inhibitors and antagonistic antibodies have shown promising data in clinical trials of lung adenocarcinoma. Finding noninvasive diagnostic tools to estimate the status of MET is helpful in clinical practice. (18)F-flu...
Autores principales: | An, Shuxian, Zhou, Xiang, Liu, Jianjun, Huang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709992/ https://www.ncbi.nlm.nih.gov/pubmed/29225472 http://dx.doi.org/10.2147/OTT.S150334 |
Ejemplares similares
-
(18)F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma
por: Huang, Ping, et al.
Publicado: (2017) -
(18)F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit (18)F-Fluorodeoxyglucose in Oncology Application
por: Li, Xiao-Feng, et al.
Publicado: (2014) -
Incidental gastrointestinal (18)F-Fluorodeoxyglucose uptake associated with lung cancer
por: Vella-Boucaud, Juliette, et al.
Publicado: (2015) -
Association between histopathological subtype, (18)F-fluorodeoxyglucose uptake and epidermal growth factor receptor mutations in lung adenocarcinoma
por: QIANG, GUANGLIANG, et al.
Publicado: (2016) -
Determinants of physiological uptake of (18)F-fluorodeoxyglucose in palatine tonsils
por: Birkin, Emily, et al.
Publicado: (2018)